Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.

Artificial DNA, PNA & XNA
Adrian G TorresMichael J Gait

Abstract

Efficient cell delivery of antisense oligonucleotides (ONs) is a key issue for their potential therapeutic use. It has been shown recently that some ONs can be delivered into cells without the use of transfection agents (gymnosis), but this generally requires cell incubation over several days and high amounts of ONs (micromolar concentrations). Here we have targeted microRNA 122 (miR-122), a small non-coding RNA involved in regulation of lipid metabolism and in the replication of hepatitis C virus, with ONs of different chemistries (anti-miRs) by gymnotic delivery in cell culture. Using a sensitive dual-luciferase reporter assay, anti-miRs were screened for their ability to enter liver cells gymnotically and inhibit miR-122 activity. Efficient miR-122 inhibition was obtained with cationic PNAs and 2'-O-methyl (OMe) and Locked Nucleic Acids (LNA)/OMe mixmers containing either phosphodiester (PO) or phosphorothioate (PS) linkages at sub-micromolar concentrations when incubated with cells for just 4 hours. Furthermore, PNA and PS-containing anti-miRs were able to sustain miR-122 inhibitory effects for at least 4 days. LNA/OMe PS anti-miRs were the most potent anti-miR chemistry tested in this study, an ON chemistry that has been l...Continue Reading

References

Apr 20, 1999·Nature Biotechnology·A Persidis
Mar 17, 2004·PLoS Biology·György HutvágnerPhillip D Zamore
Sep 6, 2005·Science·Catherine L JoplingPeter Sarnow
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
Dec 27, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Saïd AbesBernard Lebleu
Feb 7, 2006·Cell Metabolism·Christine EsauBrett P Monia
May 13, 2006·Nucleic Acids Research·Scott DavisChristine Esau
Jun 17, 2006·Cell·Suvendra N BhattacharyyaWitold Filipowicz
Oct 20, 2006·Current Opinion in Chemical Biology·Charles Wilson, Anthony D Keefe
Feb 27, 2007·Science·Robinson TribouletMonsef Benkirane
Apr 19, 2007·Nucleic Acids Research·Jan KrützfeldtMarkus Stoffel
May 18, 2007·Annual Review of Cell and Developmental Biology·Natascha Bushati, Stephen M Cohen
Nov 30, 2007·Journal of Cellular Biochemistry·Z Gunnur DikmenSergei M Gryaznov
Mar 28, 2008·Nature·Joacim ElménSakari Kauppinen
Apr 23, 2008·Current Protocols in Nucleic Acid Chemistry·John J TurnerMichael J Gait
Sep 20, 2008·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mohamed-Salah I AbazaRajaa Al-Attiyah
Oct 17, 2008·PloS One·Ming LuQinghua Cui
Nov 19, 2008·Nucleic Acids Research·Scott DavisChristine Esau
Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·C A SteinLuba Benimetskaya
Mar 13, 2010·Nucleic Acids Research·Martin M FabaniElena Vigorito
Mar 17, 2010·Chemistry & Biodiversity·Rakesh N Veedu, Jesper Wengel
Apr 3, 2010·Silence·Barbara RobertsonAnnaleen Vermeulen
Apr 29, 2010·Pharmaceutical Research·Kim A Lennox, Mark A Behlke
Jul 16, 2010·Trends in Cell Biology·Derrick Gibbings, Olivier Voinnet
Sep 16, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hui XuLiang-Hu Qu
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yi-Ping LiJens Bukh
Mar 23, 2011·Nature Genetics·Susanna ObadSakari Kauppinen
Jun 10, 2011·Nucleic Acids Research·Ashley P E RobertsCatherine L Jopling

❮ Previous
Next ❯

Citations

Apr 23, 2013·Bioorganic & Medicinal Chemistry·Christiane Schöniger, Christoph Arenz
Mar 22, 2013·BioResearch Open Access·German M TragliaMarcelo E Tolmasky
Jan 11, 2014·Expert Opinion on Therapeutic Patents·Roberto Gambari
Jan 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anisha GuptaW Mark Saltzman
Jan 21, 2012·Trends in Biotechnology·Adrian G Torres, Michael J Gait
May 29, 2012·Chembiochem : a European Journal of Chemical Biology·Alex ManicardiRoberto Corradini
May 2, 2013·Molecular and Cellular Neurosciences·Andrew G L Douglas, Matthew J A Wood
Aug 5, 2016·Chemical Biology & Drug Design·Chiranjeev Sharma, Satish Kumar Awasthi
Sep 21, 2012·International Journal of Oncology·Eleonora BrognaraRoberto Gambari
Mar 24, 2017·Nucleic Acids Research·Eman M ZaghloulC I Edvard Smith
Sep 19, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rebecca J HenryAlan I Faden
Apr 2, 2020·Yonsei Medical Journal·Qing Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.